We would love to hear your thoughts about our site and services, please take our survey here.
Punit have you been selling 30 pounds worth of shares?
Trades are all relatively small...
£93 sell. Lol,WTF
Breaking away from all other Covid 19 plays.
Hold on to your ticket. Final furlong... Shame we are racing with sellers handicap
"RE: ODX - buying againToday 08:43
They need to put more coal in the server"
And in the consortium
@ Fly
Mind reader. I suspected the same, what a better time to raise cash for the business? POC Covid19? What's that? No mate cancer treatment.
Not long ago I came across few comparative papers of Affimers Vs Antibodies, Affimers were depicted as the future of diagnostic ( and maybe they are) , the impression was that Affimers are still trying to be establish as a valid product in a antibody market.
Keep the band aids ready. I would also wear an helmet ,color matching the bohoo Sox.
Hand brake still on but a positive day after all.
Sure wait and see in 10 / 15 days. Bring the band aids
Gents,
I forgot Avacta and I am still trying to validate a solid opinion on it.
Fact :
Affimers Tec is perceived in the diagnostic industry as the ugly younger brother of the Antibodies segment.
I might take a while before the technology wins buy in and confidence.
Magsy
I got few argument in both boards regarding the future of the shares.
In Novacyt I was skeptical about the sales figures.
While they were boasting about 8 million production pipeline, if you simply had the intellectual honesty to look into the specs of the test you would have realised pretty quickly that there were significant warning flags. Temperature storage issues goods movement issues lab processing issues all the above when the price was sitting at £5. But obviously who bought in late didn't want to hear the crude facts.
Omega it's probably even worse, clumsy leadership lack of clarity on who does what and when, people still in there think they are going to bag huge on Abingdon spearhead ( the co-founder it's on Genedrive board), As I read the all thing Omega only profits for the manufacturing effort and the capacity figures circulating are from a screenshot taken from Twitter. God forbid you raise your perplexity on that board.
We are going to be just fine. On paper this is the best shot on high capacity PCR testing.
Novacyt is done out of fuel
@fly
Your posts are always on point and a good read.
If we stick to the claims of the specs this test will sell by himself. Storage temperature ranges and high sensitivity makes it a pure racer.
Some very good recovery on some of them. Hoping for a full week run before top slicing.
My dividend stock DPDHL top performer and almost fully recovered.
Back to Gene, glad I have my main play in Covid19 here. The RNS in ODX confirmed what I suspected long ago,in the RTC consortium Omega is sitting on the bench on labourers duties, manufacturing capacity figures all still to be proven.
Novacyt almost dead if you consider the output from labs with their products.
In GDR we know what's dragging and it was expected , the amazing fact is that we have fresh legs to sprint hard the last mile.
Difficult RNS to digest. Seems like the genius now clears the air on who does what and when in the relationship.
The statement from the previous RNS makes more sense now. Nailing down exact manufacturing figures is now a super priority and not just an exercise.
Samolly it's simple. In order to sell you need cash big cash if you want to do it globally.
And this was the reason for the placing and Genedrive main driver.
For the II it was a good opportunity to make quick profits and be in line with their agendas
A win win for all.
Ok sorry Tuan
Scroll back the board and you will find your answers.
@ Marve
I am actually looking into spreadex as well to understand more, but I believe they are not the one to worry about mid term.
@Tuan
Are you new from Novacyt?
@Punit
You and research do not fit well in the same sentence.
@ Mag
LoL the lollies
All,
Don't be fooled to believe that we are in the early days, things are moving fast. The next race for vaccine has a solid line up already. Keep the timeline in check